Circulating B Lymphocyte Subsets in Patients with Systemic Lupus Erythematosus

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease involving T and B cell activation, autoantibodies, and immune complex deposition.
• Understanding immunologic disturbances, especially during SLE flares, is critical but data remains limited.
• Current research focuses on identifying specific B cell subsets associated with disease activity and flares.

Purpose of the Study:

• To investigate the associations between B cell subsets, disease activity, and flares in patients with SLE.
• To explore correlations between lymphocyte subsets, complement levels, and inflammatory markers in SLE patients.
• To identify predictors of lupus flares in patients with SLE.

Main Methods:

• Investigated 35 SLE patients, categorized by disease activity (flares vs. remission) using the SLE disease activity index (SLEDAI).
• Employed flow cytometry to analyze B cell subsets, including transitional, regulatory, naïve, and memory B cells.
• Correlated B cell subset percentages with SLEDAI scores, complement levels (C3c), C-reactive protein, and disease duration.

Main Results:

• SLEDAI scores positively correlated with transitional/regulatory B cells.
• Naïve and memory B cell percentages showed associations with C3c complement levels.
• C-reactive protein correlated with plasmablast and plasmocyte percentages.
• Plasmablast percentage was associated with longer SLE duration.
• Patients who developed flares after 5 years had longer initial disease duration.

Conclusions:

• Significant associations exist between specific B cell subsets and SLE disease activity.
• B cell subset analysis may help identify SLE patients at higher risk for flares.
• Personalized approaches are essential for improved SLE management and flare prediction.